DVAX

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Peers: JNJ PFE MRNA GILD BNTX AZN REGN NVAX VIR VXRT

| Held by: IJR VTI IWM XBI IJS IBB IWO VXF SPSM PBE

Index	RUT	P/E	-	EPS (ttm)	-0.38	Insider Own	0.66%	Shs Outstand	117.36M	Perf Week	42.54%
Market Cap	1.81B	Forward P/E	29.18	EPS next Y	0.53	Insider Trans	-72.68%	Shs Float	116.65M	Perf Month	34.44%
Enterprise Value	1.45B	PEG	0.52	EPS next Q	0.04	Inst Own	97.44%	Short Float	10.54%	Perf Quarter	58.07%
Income	-43.40M	P/S	5.46	EPS this Y	-280.87%	Inst Trans	0.52%	Short Ratio	7.69	Perf Half Y	54.73%
Sales	330.51M	P/B	3.38	EPS next Y	245.71%	ROA	-4.32%	Short Interest	12.29M	Perf YTD	20.44%
Book/sh	4.55	P/C	2.79	EPS next 5Y	56.43%	ROE	-7.14%	52W High	14.63 5.13%	Perf Year	20.91%
Cash/sh	5.52	P/FCF	22.42	EPS past 3/5Y	-27.72% -	ROIC	-5.57%	52W Low	9.20 67.17%	Perf 3Y	40.71%
Dividend Est.	-	EV/EBITDA	77.48	Sales past 3/5Y	-14.08% 51.08%	Gross Margin	83.17%	Volatility	2.14% 2.30%	Perf 5Y	211.97%
Dividend TTM	-	EV/Sales	4.38	EPS Y/Y TTM	-310.39%	Oper. Margin	3.16%	ATR (14)	0.57	Perf 10Y	-40.55%
Dividend Ex-Date	-	Quick Ratio	6.94	Sales Y/Y TTM	26.73%	Profit Margin	-13.13%	RSI (14)	89.44	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	7.62	EPS Q/Q	81.60%	SMA20	37.66%	Beta	0.93	Target Price	22.00
Payout	0.00%	Debt/Eq	0.54	Sales Q/Q	17.67%	SMA50	41.81%	Rel Volume	19.24	Prev Close	11.13
Employees	405	LT Debt/Eq	0.46	Earnings	Nov 05 AMC	SMA200	42.77%	Avg Volume	1.60M	Price	15.38
IPO	Feb 19, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	66.53% 0.93%	Trades		Volume	30,747,058	Change	38.19%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-11-25	Downgrade	Goldman	Neutral → Sell	$15 → $12
Feb-01-24	Initiated	Goldman	Neutral	$20
Sep-27-22	Initiated	JMP Securities	Mkt Outperform	$22
Jan-06-22	Resumed	Goldman	Buy	$38
Aug-06-21	Initiated	Goldman	Buy	$19
Aug-07-20	Reiterated	H.C. Wainwright	Buy	$14 → $12
Aug-03-20	Reiterated	H.C. Wainwright	Buy	$12 → $14
Jun-15-20	Initiated	Evercore ISI	Outperform	$14
Oct-18-19	Initiated	H.C. Wainwright	Buy	$13
Jul-11-19	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$20
Feb-27-19	Reiterated	Cantor Fitzgerald	Overweight	$32 → $28
May-10-18	Upgrade	JP Morgan	Neutral → Overweight
Mar-08-18	Reiterated	Cantor Fitzgerald	Overweight	$25 → $27
Feb-14-18	Downgrade	JP Morgan	Overweight → Neutral
Sep-25-17	Reiterated	RBC Capital Mkts	Outperform	$26 → $28
Sep-15-17	Initiated	Cantor Fitzgerald	Overweight	$24
Jul-31-17	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$7 → $26
Jul-31-17	Upgrade	JP Morgan	Neutral → Overweight
May-09-17	Reiterated	RBC Capital Mkts	Sector Perform	$6 → $7
Apr-28-16	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$48 → $17

Show Previous Ratings

Today 10:40AM	Dynavax (DVAX) Rockets 38% on Sanofi $2-Billion Merger (Insider Monkey)
12:47AM	Asian shares are mixed after US stocks drift to more records (Associated Press Finance)
Dec-24-25 03:55PM	Why Dynavax Stock Soared Today (Motley Fool) +38.19%
02:23PM	Stocks End Mildly Higher as Bullish Sentiment Continues (Barchart)
01:24PM	How major US stock indexes fared Wednesday, 12/24/2025 (Associated Press)
01:04PM	Loading…
01:04PM	Sanofi To Buy Vaccine Maker Dynavax For $2.2 Billion (Investor's Business Daily)
12:08PM	This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. (Barrons.com)
11:55AM	Dynavax Technologies Stock Soars on Buyout Buzz (Schaeffer's Research)
11:24AM	Sanofi to Acquire Dynavax for $2.2 Billion, Expanding Vaccine Portfolio (GuruFocus.com)
11:07AM	Stock Market Today: Dow Rises As Nike Jumps On Apple CEO Stake (Live Coverage) (Investor's Business Daily)
11:07AM	Soft Weekly Jobless Claims Data (Zacks)
10:49AM	Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying (Investopedia)
10:35AM	Xmas Eve Jobless Claims: Still Accommodating (Zacks)
09:59AM	Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise (Zacks)
09:36AM	KB Home downgraded, Costco upgraded: Wall Street's top analyst calls (The Fly)
09:36AM	Loading…
09:36AM	KB Home downgrade, Costco upgraded: Wall Street's top analyst calls (The Fly)
09:24AM	BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax (Yahoo Finance Video)
07:59AM	This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. (Barrons.com)
07:43AM	Biggest Mover Wednesday: Dynavax Stock Soars on $2.2 billion Acquisition Deal (GuruFocus.com)
07:09AM	Nike, UiPath gain in premarket; Intel falls (Investing.com)
07:04AM	U.S stocks on the move in Wednesday morning pre-market trading (MarketWatch)
06:34AM	Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal (The Wall Street Journal)
04:57AM	Stock Market Today: Dow, S&P 500 and Nasdaq point to lower start ahead of shortened holiday trading session with U.S. jobless claims due later. Gold, silver and copper near record highs. (MarketWatch)
01:23AM	Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline (PR Newswire)
Dec-01-25 04:41PM	Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10 (Investor's Business Daily) -5.80%
12:35PM	Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men (MarketWatch)
10:09AM	Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths (Investor's Business Daily)
Nov-19-25 04:01PM	Dynavax to Participate at the 8th Annual Evercore Healthcare Conference (PR Newswire)
Nov-06-25 12:01AM	Dynavax Technologies Corp (DVAX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com) +6.70%
Nov-05-25 05:20PM	Dynavax Technologies (DVAX) Surpasses Q3 Earnings Estimates (Zacks)
04:18PM	Loading…
04:18PM	Dynavax Technologies: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program (PR Newswire)
04:00PM	Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program (PR Newswire)
Nov-04-25 04:15PM	Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Nov-03-25 05:55PM	Nuvation Bio Inc. (NUVB) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Oct-22-25 04:01PM	Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025 (PR Newswire)
Oct-21-25 04:01PM	Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial (PR Newswire)
Sep-22-25 10:22AM	Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last? (Zacks)
Sep-02-25 04:05AM	Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook (Insider Monkey)
Aug-27-25 04:05PM	Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference (PR Newswire)
Aug-22-25 07:25AM	Dynavaxs shingles vaccine shows promise in trial against GSKs Shingrix (Clinical Trials Arena)
Aug-21-25 08:00AM	Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile (PR Newswire) +5.09%
Aug-07-25 05:10PM	Dynavax Technologies (DVAX) Q2 Earnings and Revenues Beat Estimates (Zacks) -6.60%
04:11PM	Dynavax Technologies: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Dynavax Reports Second Quarter 2025 Financial Results (PR Newswire)
Aug-06-25 05:25PM	Protagonist Therapeutics (PTGX) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Jul-29-25 04:02PM	Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 (PR Newswire)
Jul-28-25 05:20PM	Exelixis (EXEL) Beats Q2 Earnings Estimates (Zacks)
Jul-06-25 04:15AM	Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31 (Insider Monkey)
Jun-11-25 11:01AM	Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting (PR Newswire)
Jun-09-25 08:30AM	Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom (Business Wire)
07:30AM	Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting (PR Newswire)
Jun-04-25 04:59PM	Dynavax Comments on Glass Lewis Recommendation (PR Newswire)
09:27AM	Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies (Business Wire)
May-28-25 04:10PM	Dynavax to Present at William Blair's 45th Annual Growth Stock Conference (PR Newswire)
May-23-25 06:12PM	Deep Track Capital Comments on ISS Recommendation (Business Wire)
01:44PM	Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees (PR Newswire)
May-15-25 04:00PM	Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting (Business Wire)
May-12-25 07:30AM	Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value (PR Newswire)
May-09-25 08:38PM	/C O R R E C T I O N -- Dynavax Technologies/ (PR Newswire)
May-08-25 12:00PM	Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why (Zacks)
May-07-25 04:45PM	Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum (PR Newswire) -10.99%
03:19AM	Dynavax Technologies Corp (DVAX) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
May-06-25 05:15PM	Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs (PR Newswire)
08:00AM	Deep Track Capital Releases Investor Presentation on Dynavax Technologies (Business Wire)
May-05-25 08:10AM	TG Therapeutics (TGTX) Lags Q1 Earnings Estimates (Zacks)
May-01-25 08:00AM	Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits (PR Newswire)
Apr-29-25 07:30AM	Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy (PR Newswire)
Apr-22-25 04:00PM	Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 (PR Newswire)
Apr-21-25 04:05PM	Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders (Business Wire)
Apr-17-25 09:17AM	GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP (Zacks)
07:15AM	Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders (PR Newswire)
Apr-16-25 09:48AM	MURA Soars as it Explores Strategic Options Post Cancer Study Failures (Zacks) -6.66%
08:52AM	DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up (Zacks)
08:00AM	Deep Track Capital Comments on Dynavax Technologies Rejection of Most Recent Settlement Offer (Business Wire)
Apr-15-25 10:20AM	Buy The Dips, Sell The Rips (Seeking Alpha)
Apr-11-25 11:57AM	KROS Initiates Exploring Strategic Alternatives, Stock Gains 18.5% (Zacks)
Apr-10-25 10:53AM	PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next Dose (Zacks) -8.81%
09:58AM	ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up (Zacks)
Apr-09-25 12:57PM	3 Biotech Stocks Holding Their Own (Seeking Alpha)
10:01AM	RXRX Doses First Patient in Early-Stage B-Cell Lymphomas Study (Zacks)
Apr-08-25 12:18PM	AtriCure Drops 25%: Bargain Or Caution Sign? (Seeking Alpha) -5.92%
11:29AM	PCRX Stock Soars on Exparel Patent Settlement With Generic Players (Zacks)
11:21AM	RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study (Zacks)
Apr-07-25 10:53AM	AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs (Zacks)
Apr-04-25 01:45PM	Bayer's Vividion Initiates Dosing in Early-Stage Cancer Study (Zacks)
01:10PM	AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication (Zacks)
09:37AM	PCRX Doses First Patient in Phase II PCRX-201 Gene Therapy Study (Zacks)
Apr-03-25 05:40PM	Dynavax Files Preliminary Proxy Statement (PR Newswire)
11:27AM	SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases (Zacks)
09:32AM	DNLI Begins Rolling BLA Submission for Hunter Syndrome Drug, Stock Up (Zacks)
Apr-02-25 11:29AM	AXSM Stock Down on Top-Line Data From Depression Study on Solriamfetol (Zacks)
Apr-01-25 10:55AM	VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates (Zacks)
09:31AM	AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication (Zacks)
Mar-31-25 09:57AM	Moderna, biotech stocks slide following resignation of FDA official Peter Marks (Yahoo Finance) -5.19%
Mar-28-25 09:45AM	Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus (Zacks)
09:26AM	BEAM's IND for BEAM-302 in Genetic Disorder Study Gets FDA Clearance (Zacks)
Mar-27-25 12:37PM	Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharma (Zacks)
09:39AM	PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know (Zacks)

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Myers Scott Dunseth	Director	Aug 22 '25	Buy	10.82	3,800	41,116	35,004	Aug 25 08:50 AM
Deep Track Biotechnology Maste	10% Owner	Aug 21 '25	Sale	11.03	1,094,994	12,077,784	16,696,492	Aug 22 08:49 PM
Deep Track Biotechnology Maste	10% Owner	Aug 22 '25	Sale	10.59	970,143	10,273,814	15,726,349	Aug 22 08:49 PM
Novack David F	President & COO	Mar 24 '25	Option Exercise	6.80	10,000	68,050	18,078	Mar 26 05:04 PM
Novack David F	President & COO	Mar 24 '25	Sale	14.00	10,000	140,000	8,078	Mar 26 05:04 PM
DAVID NOVACK	Officer	Mar 24 '25	Proposed Sale	14.00	10,000	140,000		Mar 24 04:23 PM
Novack David F	President & COO	Mar 18 '25	Sale	13.58	14,020	190,392	8,078	Mar 20 06:15 PM
DAVID NOVACK	Officer	Mar 18 '25	Proposed Sale	13.58	14,020	190,386		Mar 18 04:17 PM
Novack David F	President & COO	Mar 07 '25	Sale	14.39	32,764	471,474	22,098	Mar 10 09:44 PM
DAVID NOVACK	Officer	Mar 07 '25	Proposed Sale	14.39	32,764	471,376		Mar 07 05:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Dynavax Technologies Corp

Upgrade your FINVIZ experience